[Immunological mechanism affecting oncolysis by Clostridium butyricum].
D000818:Animals; D000906:Antibodies / Q000302:isolation & purification; D000937:Antigen-Antibody Reactions; D002286:Carcinoma, Ehrlich Tumor / Q000188:drug therapy*; D003013:Clostridium; D003036:Cobalt Isotopes; D007109:Immunity / Q000187:drug effects / Q000528:radiation effects; D007110:Immunity, Active; D007112:Immunity, Maternally-Acquired; D007114:Immunization; D007165:Immunosuppression Therapy; D051379:Mice; D008815:Mice, Inbred Strains; D009368:Neoplasm Transplantation; D009369:Neoplasms / Q000209:etiology; D011239:Prednisolone / Q000494:pharmacology; D011817:Rabbits; D011830:Radiation Effects; D013171:Spores, Bacterial / Q000276:immunology / Q000302:isolation & purification; D014118:Toxins, Biological / Q000627:therapeutic use*; D014184:Transplantation, Homologous
D000906:Antibodies; D003036:Cobalt Isotopes; D014118:Toxins, Biological; D011239:Prednisolone
Der Einfluss der Immunabwehr auf den onkolytischen Effekt von Clostridium butyricum.